Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6,887,242
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
2,083,045
-
Shares change
-
+458,641
-
Total reported value, excl. options
-
$8,477,419
-
Value change
-
+$1,866,030
-
Number of buys
-
11
-
Number of sells
-
5
-
Price
-
$4.07
Institutional Holders of Aprea Therapeutics, Inc. - Common Stock (APRE) as of Q2 2024
As of 30 Jun 2024 Aprea Therapeutics, Inc. - Common Stock (APRE) had 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,083,045 shares of stock of the company.
Largest 10 holders included AIGH Capital Management LLC, Sio Capital Management, LLC, SPHERA FUNDS MANAGEMENT LTD., Nantahala Capital Management, LLC, Altium Capital Management LP, DAFNA Capital Management LLC, Stonepine Capital Management, LLC, Exome Asset Management LLC, VANGUARD GROUP INC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 30 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.